UPDATE : Tuesday, March 20, 2018
Novartis’ breast cancer therapy wins FDA breakthrough designation by Marian Chu 2018-01-04 10:44
Regulators okay Abbott Korea’s house dust mite allergy treatment by Lee Han-soo 2018-01-03 17:38
Seegene develops 1st molecular diagnostic reagent using AI by Lee Han-soo 2018-01-03 12:12
Anticoagulant latecomer Lixiana outperforms Pradaxa by So Jae-hyeon 2018-01-03 10:56
Green Cross changes its name to GC Pharma by Lee Han-soo 2018-01-02 16:48
Samsung BioLogics denies accounting fraud allegations by Lee Han-soo 2018-01-02 11:52
Genexine, I-MAB sign $548 million deal to develop cancer drug in China by Marian Chu 2017-12-27 15:30
SNUH’s lab to use Medidata’s clinical cloud platform by Marian Chu 2017-12-22 15:31
Handok to sell Actelion’s hypertension drug Uptravi by Marian Chu 2017-12-22 10:46
C-TRI begins local clinical trial for spinal disease treatment by Marian Chu 2017-12-22 09:49
LG Chem’s diabetes drug Zemiglo sees fast sales growth by Lee Han-soo 2017-12-21 12:35
Huons Global starts local clinical trial for Hutox by Lee Han-soo 2017-12-21 11:30
Huons, SMB sign license agreement for Zephirus by Lee Han-soo 2017-12-20 17:07
SK Chemicals starts domestic supply of ‘Skyzoster’ by Lee Han-soo 2017-12-20 14:37
AstraZeneca to test asthma treatment in Korea by Lee Hye-seon 2017-12-20 13:11
Pfizer gets nod for Gleevec-topping leukemia drug by Marian Chu 2017-12-20 11:08
Exelixis gets early FDA okay to use cancer drug by Marian Chu 2017-12-20 10:37
 Ferring’s oral colonoscopy preparation solution obtains FDA approval by Lee Han-soo 2017-12-19 17:02
GemVax wins patent for personalized-tissue engineered vein technology by Lee Han-soo 2017-12-19 16:16
Will Takeda, Dong-A ST benefit from new hypertension guideline? by Nam Doo-hyun 2017-12-19 16:15
Back to Top